Filter
806
Filtered Results: 806
Text search:
Ministry
of
Health,
Ghana,
World
Health
Organizaiotn
(WHO)
and
Ghana
Health
Service
Featured
Recommendations
58
New Publications
202
Language
Document type
No document type
455
Studies & Reports
171
Guidelines
86
Manuals
48
Strategic & Response Plan
26
Fact sheets
8
Training Material
5
Situation Updates
4
Brochures
1
App
1
Resource Platforms
1
Countries / Regions
Ghana
78
Global
45
Sierra Leone
34
Africa
33
Liberia
31
Kenya
29
Uganda
24
Nigeria
21
Ethiopia
19
Guinea
18
Malawi
17
Zambia
14
Senegal
13
Tanzania
11
Rwanda
11
South Africa
11
Cameroon
10
Benin
10
Zimbabwe
9
West and Central Africa
9
Burkina Faso
8
Nepal
7
Congo, Democratic Republic of
6
Mozambique
6
Namibia
6
East and Southern Africa
6
Latin America and the Carribbean
6
Mali
5
India
5
Côte d’Ivoire / Ivory Coast
4
Togo
4
Botswana
4
Guinea-Bissau
3
Chad
3
Cambodia
3
Bangladesh
3
Western and Central Europe
3
Niger
2
Haiti
2
South Sudan
2
Afghanistan
2
Syria
2
Thailand
2
Gambia
2
China
2
Indonesia
2
Central African Republic
2
Eswatini/ Swaziland
2
Ukraine
2
South–East Asia Region
2
USA
1
Philippines
1
Somalia
1
Jordan
1
Sudan
1
Peru
1
Brazil
1
Colombia
1
Ecuador
1
Greece
1
Angola
1
Madagascar
1
Lesotho
1
Mexico
1
Myanmar / Burma
1
Sri Lanka
1
Yemen
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Asia
1
Eastern Europe
1
Palestine
1
Laos
1
Mauritius
1
Morocco
1
Authors & Publishers
Publication Years
Category
Countries
264
Public Health
67
Clinical Guidelines
63
Women & Child Health
50
Key Resources
41
Capacity Building
19
Pharmacy & Technologies
11
Toolboxes
HIV
70
Mental Health
53
Disability
46
Ebola
38
Planetary Health
37
Caregiver
36
NTDs
36
AMR
35
COVID-19
35
Rapid Response
28
TB
28
Pharmacy
23
Global Health Education
21
NCDs
14
Health Financing Toolbox
10
Refugee
9
Conflict
4
Cholera
3
Polio
2
Natural Hazards
2
Social Ethics
2
Specific Hazards
1
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge ... evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infectious diseases in the ministries of health (especially but not limited to endemic countries), nongovernmental organizations, clinicians, pharmaceutical companies, donors and affected persons
The World Health Organization organized a Consultation of National Leprosy Programme managers, p...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium ... indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators presented in the M&E framework. These indicators will also support reporting on strategies described in other road map companion documents to guide action against neglected tropical diseases include the sustainability framework, the global strategy on water, sanitation and hygiene, the One Health approach and the strategic framework for integrated control and elimination of skin-related neglected tropical diseases.
The purpose of this compendium is to guide monitoring and evaluation of programmes and thereby to improve their quality and effectiveness in alignment with the road map goals. It provides a standardized listing of the most widely used indicators relevant to countries, with uniformity in defining indicators to allow comparisons over time and among different programmes. Detailed metadata are provided for each of these indicators to facilitate validity, internal consistency, standardized measurement, estimation methods and comparability of data across countries.
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use ... placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This policy brief was developed by the WHO Access to COVID-19 Tools (ACT) Accelerator Ethics & Governance Working Group, to provide guidance for researchers, sponsors, regulators, research ethics committees, and policy-makers, on these and related issues.
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This ...
This document provides up-to-date guidance on laboratory studies as well as smallscale (semi-field) and large-scale field trials to assess the efficacy and determine field
application rates ... new molluscicide products for control of schistosomiasis.
The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT ... the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’Ivoire, Chad, Democratic Republic of the Congo, Guinea and Uganda). Country reports focused on the in situations implementing and supporting vector control activities, the tools and the approaches in use, the coverage of the activities in space and time and their impacts on tsetse populations. Future perspectives for vector control in the respective countries were also discussed, including opportunities and challenges to sustainability.
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts t...
The overall goal of this strategy is to ensure accurate understanding of the
benefits of covid-19 vaccination ... alleviate apprehension about the vaccine, to ensure its acceptance and encourage uptake across various audiences.
Objectives
x Create demand, promote acceptability and accessibility of COVID-19
vaccine among at least 90% of the general public.
x Develop appropriate messages and identify channels to communicate
the potential benefits and risks of the vaccine to all concerned parties,
including decision-makers at all levels.
x Provide timely and accurate information to address misinformation,
rumors and other crisis situations.
x Effectively mobilize and empower communities to ensure participation
and ownership of the vaccination process
x Strengthen communication mechanisms and partnerships among key
stakeholders to support the national communication effort.
The World Health Organization (WHO) convened a meeting ... the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
Epilepsy: a public health imperative
recommended
This is the first global report on epilepsy summarizing the available evidence on the burden of epilepsy and the public health response required at...
Discussion paper initially prepared in April 2015 to facilitate feedback, and finalized after the
June 2015 meeting of WHO’s Strategic ... Technical Advisory Group for TB (STAG-TB).
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in ...
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end ... life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukemia, lung and prostate. The first section defines the global increase in cancer cases, the global goals to manage NCDs and the WHO activities related to these goals. The second section presents the methodology used for the selection of medical devices that support clinical interventions required to screen, diagnose, treat and monitor cancer stages, as well as the provision of palliative care, based on evidence-based information. The third section lists the priority medical devices required to manage cancer in seven different units of health care services: 1. Vaccination, clinical assessment and endoscopy, 2. Medical imaging and nuclear medicine, 3. Surgery, 4. Laboratory and pathology, 5. Radiotherapy, 6. Systemic therapy and 7. Palliative and end of life care
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring ... evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicine-related adverse effects in humans, promoting patient safety, and the rational use of medicines. The indicators proposed in this manual are based on the expected functions of pharmacovigilance centres as described in the WHO Mimimum Requirements for a Functional Pharmacovigilance System (1) (see Annex 1 of the manual).
WHO published the first COVID-19 Strategic Response and Preparedness Plan (SPRP) on 3 February, 2020. This report highlights the main points of pro...
This guideline provides evidence-informed guidance on the use of non-sugar sweeteners to reduce the risk of unhealthy weight gain and diet-related...
The Transformation Agenda (TA) ushered in an ambitious reform process intended to transform the World Health Organization (...) into an organization that is proactive, results-driven, accountable and which meets stakeholder expectations, towards transforming and improving public health services in the African Region. It aimed to achieve a WHO that is pro-results, which optimally and creatively targets technical work as well as make operations more responsive, with greater effectiveness in both communications and partnerships. The Africa Region has been the epicentre of the human immunodeficiency virus (HIV) epidemic and it’s one of the leading causes of disease and death on the continent. The WHO, with partners, has worked tirelessly for many years to control the threat and reduce the negative impact of the disease. Since the early 2000s, significant progress has been made in the global fight against the scourge of HIV. However, the WCA subregion was falling concerningly behind ESA on several key indicators of progress. In 2016, the WHO joined UNAIDS, UNICEF and other partners in a call for a strong and urgent response to support WCA countries to develop catch-up plans to triple and fast-track ART coverage, to enable the region to catch up with ESA by the end of 2020. Implementation of a widespread test-and-treat strategy, coupled with the scale-up of differentiated service delivery (DSD) and mobilization of requisite funding, accelerated WCA’s progress towards this goal. The HIV treatment catch-up and fast-track plan has achieved its target of seeing the West and Central African region (WCA) catch up with the Eastern and Southern African region’s (ESA) antiretroviral coverage rate of 78% in 2021, albeit later than the 2020 target time frame. A 33% improvement was achieved in WCA, against 21% in ESA, between 2015–2020. WCA achieved a significant 42% increase, compared to ESA’s 23%, between 2015 and 2021, to see WCA draw level with ESA at 78%. In the Democratic Republic of the Congo (DRC) alone, progress of up to 47% was observed between 2015 and 2020, for example. In addition, 1.6 million more People Living with HIV (PLHIV) were enrolled on antiretroviral treatment (ART) between 2015 and 2020.
The WHO Quality Health Services: a planning guide focuses on actions required at the national, district and facility levels to enhance quality ... health services, providing guidance on implementing key activities at each of these three levels. It highlights the need for a health systems approach to enhance quality of care, with a common understanding on the activities needed by all stakeholders. The guide articulates the key actions required to improve the quality of health services for the entire population. It recognizes that the path varies for each country, district and facility – stimulating the reader to consider multiple factors and entry points for action. This planning guide is for staff working at all levels of the health system (i.e. national, district and facility) who have a role in enhancing the quality of health services. It is also relevant to all stakeholders initiating and supporting action at facility, district and/or national levels both in the public and private sectors.
Annual and medium-term budget preparation processes are the platforms through which specific plans are transformed into actual resource allocation decisions. The aim of this Process Guide is to supp...
